Emily Baumrin, MD, MSCE
Assistant Professor of Dermatology at the Hospital of the University of Pennsylvania
Director, Graft-versus-host Disease Subspecialty Clinic, Department of Dermatology, University of Pennsylvania
Full Member (research) in Hematologic Malignancies, Abramson Cancer Center, University of Pennsylvania
Department: Dermatology
Contact information
3400 Civic Center Boulevard
Perelman Center for Advanced Medicine, South Tower, Suite 729
Philadelphia, PA 19104
Perelman Center for Advanced Medicine, South Tower, Suite 729
Philadelphia, PA 19104
Office: (215)-614-0700
Publications
Education:
BA (Biochemistry)
Dartmouth College, 2010.
MD (Medicine)
University of Pennsylvania, Perelman School of Medicine, 2015.
MSCE (Epidemiology)
University of Pennsylvania, 2023.
Permanent linkBA (Biochemistry)
Dartmouth College, 2010.
MD (Medicine)
University of Pennsylvania, Perelman School of Medicine, 2015.
MSCE (Epidemiology)
University of Pennsylvania, 2023.
Description of Clinical Expertise
GVHD, complex medical dermatologyDescription of Research Expertise
GVHD, patient-reported outcomes, instrument development, epidemiologySelected Publications
Baumrin E, Cronholm PF, Kearney MD, Mengesha M, Cesar LG, Keddem S, Schapira MM, Lee SJ, Loren AW, Gelfand JM.: Outcomes of Importance to Patients Living With Cutaneous Chronic Graft-vs-Host Disease. JAMA Dermatol Jan 2025.Alvarado SM, Cohen OG, Lattanzio K, Haun P, Gelfand JM, Loren AW, Chung J, Baumrin E.: Histopathologic Analysis of Chronic Cutaneous Graft-Versus-Host Disease. Am J Dermatopathol Sep 2024.
Pidala JA, Onstad L, Baumrin E, Carpenter PA, Cutler CS, Arai S, Kitko CL, Chen GL, Lee SJ.: Comparison of treatment response measures in cutaneous sclerosis after allogeneic hematopoietic cell transplantation. Blood Adv Jun 2024.
Choe J, Shields A, Ferreira A, Gold S, Gotschall JW, Kamal K, Rios A, Wang RH, Baumrin E, Dommasch ED, Yeung H, Lipoff JB, Barbieri JS.: Isotretinoin for Acne in Transgender and Gender-Diverse Individuals Receiving Masculinizing Hormone Therapy. JAMA Dermatol May 2024.
Baumrin E, Shin DB, Mitra N, Pidala J, El Jurdi N, Lee SJ, Loren AW, Gelfand JM.: Patient-Reported Outcomes and Mortality in Cutaneous Chronic Graft-vs-Host Disease. JAMA Dermatol 160(4): 393-401, Apr 2024.
Rastogi S, Kim EJ, Gelfand JM, Loren AW, Baumrin E.: Chronic Graft-versus-Host Disease-Associated Muscle Cramps: Severity and Response to Immunomodulatory Therapies. Transplant Cell Ther 30(3): 338, Mar 2024.
Mital R, Otto TS, Savu A, Baumrin E, Cardones AR, Carlesimo M, Caro G, Freites-Martinez A, Hirner JP, Markova A, McLellan BN, Rossi A, Sauder MB, Seminario-Vidal L, Sibaud V, Owen DH, Dulmage BO, Chen ST, Kaffenberger BH: Detection of novel therapies using a multi-national, multi-institutional registry of cutaneous immune-related adverse events and management. Int J Dermatol 62(8): 1020-1025, May 2023.
Baumrin E, Baker LX, Byrne M, Martin PJ, Flowers ME, Onstad L, El Jurdi N, Chen H, Beeghly-Fadiel A, Lee SJ, Tkaczyk ER: Prognostic Value of Cutaneous Disease Severity Estimates on Survival Outcomes in Patients With Chronic Graft-vs-Host Disease. JAMA Dermatol 159(4): 393-402, Apr 2023.
Willer QA, Bowers JT, Baumrin E, Lipoff JB: Establishment of a dermatology clinic serving both patients living with HIV/AIDS and transgender individuals (PRIDE clinic) in an urban academic setting: Demographics, evolution, and lessons learned. J Am Acad Dermatol 88(4): 882-885, Oct 2022.
Vakili S, Paneru B, Guerrier CM, Miller J, Baumrin E, Forrestel A, Lynn K, Frank I, Lo Re V 3rd, Collman RG, Hill DA: Altered adipose tissue macrophage populations in people with HIV on integrase inhibitor-containing antiretroviral therapy. AIDS 36(11): 1493-1500, Sep 2022.